Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine. [PDF]
Am J Trop Med Hyg, 2022 Duffin RP +4 more
europepmc +3 more sources
Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. [PDF]
PLoS ONE, 2014 There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera.
Jacqueline Deen +2 more
doaj +1 more source
Oral Vaccines Against Cholera [PDF]
Clinical Infectious Diseases, 2011 The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
Sunheang, Shin +3 more
openaire +2 more sources
Immunogenicity of cholera vaccination in children with inflammatory bowel disease
Human Vaccines & Immunotherapeutics, 2021 The cholera vaccine can protect patients with inflammatory bowel disease (IBD) against both cholera and travelers’ diarrhea. However, both immunosuppressive treatment and IBD can affect its vaccine immunogenicity.
Łukasz Dembiński +5 more
doaj +1 more source
Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. [PDF]
PLoS Neglected Tropical Diseases, 2012 Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine. Balancing this concern is the
Ramadhan Hashim +24 more
doaj +1 more source
Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012 [PDF]
, 2013 During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response.
A Boutonnier +24 more
core +13 more sources
Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects. [PDF]
PLoS Neglected Tropical Diseases, 2018 Oral cholera vaccination is an approach to preventing outbreaks in at-risk settings and controlling cholera in endemic settings. However, vaccine-derived herd immunity may be short-lived due to interactions between human mobility and imperfect or waning ...
Corey M Peak +3 more
doaj +1 more source
Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. [PDF]
, 2012 In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its use in Sub-Saharan Africa has been limited ...
Ali Djibo +22 more
core +3 more sources
Advances in enteric disease vaccines: from innovation to implementation [PDF]
, 2014 The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core +1 more source
Stemming cholera tides in Zimbabwe through mass vaccination
International Journal of Infectious Diseases, 2020 Background: In 2018, Zimbabwe declared another major cholera outbreak a decade after recording one of the worst cholera outbreaks in Africa. Methods: A mathematical model for cholera was used to estimate the magnitude of the cholera outbreak and ...
Zindoga Mukandavire +5 more
doaj +1 more source